Observational studyCancer immunology, immunotherapy : CII2026
Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective study.
Jingyuan Wen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.